A Novel Combination Oral Agent to Treat Acne Vulgaris

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

13 Years to 60 Years (Child, Adult)

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

Healthy females 13 years of age or older

Non-pregnant, non-lactating females

Signed written informed consent form

Must be able to understand and be willing to follow all study instructions

Have a clinical diagnosis of acne vulgaris

Exclusion Criteria:

Female subjects who are pregnant or nursing

Any concomitant dermatologic condition that may affect outcome measures

Concurrent use of any other medication to treat acne vulgaris

Have a history or clinical evidence of any other active acute or chronic medical disease or condition considered by the principal investigator as unsuitable for the study

Are currently using any other investigational agent or device

Have participated in any other clinical study within 90 days prior to enrollment